C-1311

[ Density]:
1.32g/cm3

[ Boiling Point ]:
605.8ºC at 760mmHg

[ Molecular Formula ]:
C₂₀H₂₂N₄O₂

[ Molecular Weight ]:
350.41400

[ Flash Point ]:
320.2ºC

[ Exact Mass ]:
350.17400

[ PSA ]:
69.87000

[ LogP ]:
2.97100

[ Vapour Pressure ]:
2.86E-15mmHg at 25°C

[ Index of Refraction ]:
1.68

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302

[ RIDADR ]:
NONH for all modes of transport

Click to get detail synthetic route

Precursor

DownStream

DNA-damaging imidazoacridinone C-1311 induces autophagy followed by irreversible growth arrest and senescence in human lung cancer cells.

J. Pharmacol. Exp. Ther. 346(3) , 393-405, (2013)

Imidazoacridinone 5-diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) is an antitumor inhibitor of topoisomerase II and FMS-like tyrosine kinase 3 receptor. In this study, we describe the uni...

Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use.

Drug Metab. Dispos. 41(2) , 414-21, (2013)

The acridinone derivates 5-dimethylaminopropylamino-8-hydroxytriazoloacridinone (C-1305) and 5-diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) are promising antitumor agents with high activ...

Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form.

J. Pharm. Biomed. Anal. 39(1-2) , 46-53, (2005)

C1311 (5-[[2-(diethylamino)ethyl]amino]-8-hydroxyimidazo [4,5,1-de]-acridin-6-one-dihydrochloride trihydrate) is the lead compound from the group of imidazoacridinones, a novel group of rationally des...

More Articles